Xilio Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Xilio Therapeutics Total Assets Growth & History (XLO)
Xilio Therapeutics's total assets was $154.7M for fiscal 2025.
View full Xilio Therapeutics company overviewXilio Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $154.7M | $83.6M | +117.64% |
| 2024 | 2024-12-31 | $71.1M | $10.1M | +16.66% |
| 2023 | 2023-12-31 | $60.9M | −$78.2M | −56.22% |
| 2022 | 2022-12-31 | $139.2M | −$78.9M | −36.18% |
| 2021 | 2021-12-31 | $218.1M | $181.7M | +500.44% |
| 2020 | 2020-12-31 | $36.3M | — | — |
Xilio Therapeutics quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $154.3M | $20.4M | +15.28% |
| Q1 2026 | 2026-03-31 | $163.5M | $59.8M | +57.63% |
| Q4 2025 | 2025-12-31 | $154.7M | $83.6M | +117.64% |
| Q3 2025 | 2025-09-30 | $133.7M | $59.0M | +79.08% |
| Q2 2025 | 2025-06-30 | $133.8M | $43.9M | +48.89% |
| Q1 2025 | 2025-03-31 | $103.7M | $21.1M | +25.55% |
| Q4 2024 | 2024-12-31 | $71.1M | $10.1M | +16.66% |
| Q3 2024 | 2024-09-30 | $74.7M | −$3.2M | −4.09% |
| Q2 2024 | 2024-06-30 | $89.9M | −$2.5M | −2.69% |
| Q1 2024 | 2024-03-31 | $82.6M | −$28.9M | −25.91% |
| Q4 2023 | 2023-12-31 | $60.9M | −$78.2M | −56.22% |
| Q3 2023 | 2023-09-30 | $77.8M | −$79.6M | −50.55% |
| Q2 2023 | 2023-06-30 | $92.4M | −$85.8M | −48.15% |
| Q1 2023 | 2023-03-31 | $111.5M | −$84.8M | −43.21% |
| Q4 2022 | 2022-12-31 | $139.2M | −$78.9M | −36.18% |
| Q3 2022 | 2022-09-30 | $157.4M | $36.7M | +30.39% |
| Q2 2022 | 2022-06-30 | $178.1M | — | — |
| Q1 2022 | 2022-03-31 | $196.4M | — | — |
| Q4 2021 | 2021-12-31 | $218.1M | $181.7M | +500.44% |
| Q3 2021 | 2021-09-30 | $120.7M | — | — |
| Q4 2020 | 2020-12-31 | $36.3M | — | — |
Xilio Therapeutics total assets trends
Over the last five fiscal years, Xilio Therapeutics's total assets increased from $36.3M to $154.7M, a change of $118.4M. The latest reported quarter, Q2 2026, shows $154.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xilio Therapeutics source filings ↗